All Stories

  1. Prediction of potential biomarkers and therapeutic targets in HIV viremic patients using immune-related circRNA-miRNA-mRNA regulatory networks
  2. Orientation of Gp96 and Calreticulin T-cell epitopes in a multiepitope HPV16 E7 vaccine construct affects predicted immunostimulatory properties: An in silico and expression validation study
  3. Effective Plant-Derived Proteins and Peptides in Leukemia Treatment
  4. Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1
  5. Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects
  6. Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
  7. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies
  8. Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model
  9. HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?
  10. In vitro Anti-HIV-1 Activity of the Recombinant HIV-1 TAT Protein Along With Tenofovir Drug
  11. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches
  12. Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials
  13. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections
  14. Pharmaceutical approaches for treatment of Hepatitis C virus
  15. Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells
  16. Cell penetrating peptides: the potent multi-cargo intracellular carriers
  17. Induction of a Robust Humoral Response using HIV-1 VLPMPER-V3 as a Novel Candidate Vaccine in BALB/c Mice
  18. Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients
  19. Analysis of long non-coding RNA expression in hemophilia A patients
  20. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant
  21. Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia A
  22. Generation of the Fluorescent HPV16 E7 Protein for Detection of Delivery In vitro
  23. Antiviral Effects of Saffron and its Major Ingredients
  24. Diagnosis of HPV Infections, HPV Testing in Patients
  25. Future Prospects in HPV Prevention and Treatment
  26. General Description of HPVs
  27. HPV Proteins and Their Functions
  28. Immunity against HPV-Related Cancers
  29. Natural History of HPV Infections in Cancer Development
  30. Preclinical and Clinical Experiments on HPV Vaccines
  31. Prevention of HPV-Associated Diseases
  32. Side Effects of HPV Vaccines
  33. The Life Cycle and Transmission of HPV Types
  34. Therapeutic HPV Vaccines: Immunogenicity, Efficacy and Safety
  35. Treatment and Follow up of HPV Infection- Related Cancers
  36. Types of Benign or Malignant Diseases Associated with HPV Infections
  37. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell
  38. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines
  39. Comparison of HCV core and coreE1E2 virus-like particles generated by stably transfected Leishmania tarentolae for stimulation of Th1 immune responses in mice
  40. Cancer Chemoprevention by Natural Carotenoids as an Efficient Strategy
  41. Immunostimulant Properties of Chemical Delivery Systems in Vaccine Development